tiprankstipranks

Myriad Genetics downgraded to Equal Weight from Overweight at Wells Fargo

Wells Fargo analyst Brandon Couillard downgraded Myriad Genetics (MYGN) to Equal Weight from Overweight with a price target of $6, down from $22.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1